Chair, Department of Neurologic Surgery
Mayo Clinic
Dr. Gelareh Zadeh, MD, PhD, FRCS(C), FAANS, Chair and Professor, Department of Neurologic Surgery, Mayo Clinic, Rochester, MN and Professor of University of Toronto. She is Harold & Esther Halpern Chair and was the Head of the Division of Neurosurgery at Toronto Western Hospital University Health Network and Co-Director for the Krembil Brain Institute at University Health Network. Dr. Zadeh has a dedicated skull base and neuro-oncology practice, with a number of multidisciplinary specialized programs including a skull base clinic, brain metastases, pituitary clinic, and neurofibromatosis clinics.
Dr. Zadeh is a Senior Scientist at Princess Margaret Cancer Centre where she runs a translational research program at MacFeeters-Hamilton Neuro-oncology Program and holds the Wilkins Family Brain Tumor Research Chair. She has an active research laboratory focusing on integrated multi-platform molecular analysis of brain tumors, together with a focus on understanding molecular response to targeted therapies, such as anti-angiogenesis and metabolic inhibitors. She has published impactful investigative research in Cancer Cell, Nature Communication, Nature, Nature Medicine and her research has translated to direct advances in clinical care. She has consistent peer-review funding from CIHR, NIH, DOD, CCS, Terry Fox, Brain Tumor Charity, UK. Her contributions have been recognized through awards such as most recently the prestigious Gairdner Momentum Award, the P. Rawl Prize from Canadian Cancer Research Society, American Brain Tumor Translational Research Award and many others.
At a Provincial level she had served as the Co-Chair of the Provincial Neurosurgery Advisory Committee as well as Neurosurgery Clinical Lead role at Ontario Health
Nationally and internationally she is involved in a number of organizations. She served as the President of Society of Neuro-Oncology (SNO), Scientific Chair of Tumor Section of American Association of Neurological Surgery/Congress of Neurological Surgeons, Chair of Women in Neurosurgery Committee, WFNS as well as being the co-founder of the International Consortium on Meningiomas (ICOM) and Editor-in-Chief of Neuro-Oncology Advances, an open access journal of SNO and EANO.
Disclosure(s): No financial relationships to disclose
Saturday, April 26, 2025
8:29 AM – 8:31 AM EDT
Molecular Targeted Therapy of Skull Base Tumors
Sunday, April 27, 2025
2:23 PM – 2:33 PM EDT